Hyderabad International Convention Centre (HICC), Hyderabad

PROCEEDINGS

Hyderabad International Convention Centre (HICC), Hyderabad PROCEEDINGS
	TIME SESSION ON Day 1 - February 3, 2010 08.00 – 13.00 Bioparks Visit Biopharma / Medical Biotechnology Track Visit and session to Genome Valley – Biotech Parks / ICICI Knowledge Park Agri Biotechnology / Animal Biotechnology Track Visit to International Crop Research Institute for the Semi Arid Tropics (ICRISAT) / Indian Immunologicals Ltd 14.00 Departure to Hyderabad City after lunch 14.00 Onwards Registration at Hyderabad International Convention Center (HICC) 16.00 – 17.00 High Tea and Networking Reception 17:00-17.02 Arrival of dignitaries and presentation of bouquets 17:02-17:05 Welcome Address by Prof. Seyed E. Hasnain, Chairman, BioAsia 2010 Advisory Board 17:05-17.10 Address by Mr. Josep Hugueti Biosca, Hon’ble Minister of Innovation, Universities and Enterprise, Catalonia Government, Spain 17:10-17:15 Shri Kanna Lakshmi Narayana, Hon’ble Minister for Major Industries, Commerce & Export Promotion, Food Processing, Govt. of AP 17.15-17.30 Keynote address by Prof. M. K. Bhan, Secretary to the Govt. of India, Department of Biotechnology, New Delhi 17:30-17:35 Presentation of Genome Valley Excellence Award to Prof. C. R. Rao, Director of the centre for Multivariate Analysis, Pennsylvania State University, USA by Shri. K. Rosaiah, Hon’ble Chief Minister of Andhra Pradesh Prof. Janet Thornton, Director of EMBL European Bio-informatics institute, Cambridge, UK by Shri. Prithviraj Chavan, Hon’ble Minister for Science and Technology, Govt. of India 17:35-17:40 Acceptance speech by Prof. C. R. Rao and Prof. Janet Thornton 17.40-17.45 Unveiling of plaque to mark the inauguration of Alexandria Facility at Genome Valley 17:45-17:55 Presidential Address by Shri. Prithviraj Chavan, Hon’ble Minister for Science and Technology, Govt. of India 117:55-18.05 Inaugural Address by Shri. K. Rosaiah, Hon’ble Chief Minister of Andhra Pradesh 18.05-18.08 Presentation of Mementos to the Guests 18.08-18.10 Vote of Thanks by Mr. Sam Bob, I.A.S., Chairman, BioAsia 2010 Organising Committee 18.20- 18.45 Distinguished lecture 1 - Mr. Joel S. Marcus , Chairman, CEO & President, Alexandria Real Estate Equities, Inc. USA 18.45 -19.05 Distinguished Lecture 2 - Prof. C.R. Rao, Genome Valley Excellence Awardee 19.05 -19.30 Distinguished Lecture 3 - Prof. Janet Thornton, Genome Valley Excellence Awardee (Data for Life: Challenges for Bioinformatics) 19.30 -19.55 Distinguished lecture 4 - Dr. Maive Rute, Director General, Agriculture, Food and Biotechnology, European Commission, Brussels (European research for facing the challenges of the 21st century) 20.00 onwards Biobanquet Dinner Day 2 – February 4, 2010 Time (Hrs) Programme / Tracks 08:00 onwards Registrations Continues… 9.00 – 10.00 Panel Discussion (Common for all tracks) “Public Private Partnership in Life Sciences” - Coordinated by Mr. Utkarsh Palnitkar, Partner, Ernst and Young, Hyderabad 10.00-11.00 Plenary Lectures (Common for all tracks) Lecture I: Dr. Alfredo Aguilar, Head of Unit Biotechnology, Directorate of Food, Agriculture and Biotechnology, European Commission Lecture II: Dr. Ganesh Kishore, CEO of Malaysian Government Investment Branch (Accelerating Investments in Life Sciences - the time is now!) 11:00-11:30 Tea / coffee Break   Medical Biotechnology (Mb) Coordinators: Dr. Gurunath Reddy Dr. CM Habibullah, CLRD Dr. Vijayakumar, NIMS Biopharmaceuticals (Bp) Coordinators: Prof. P. Reddanna, Univ. of Hyd. Agri Biotechnology (Ag) Coordinator: Dr. Kiran Sharma, ICRISAT Animal Biotechnology (An) Coordinators: Dr. Channa Reddy, Penn. State Univ. Dr. Satish Kumar, CCMB 11:30-13:00 Session Mb I STEM CELL THERAPY I Chairmen: Dr. C. M. Habibullah Director Deccan College of Medical Sciences Hyderabad, INDIA and Dr. Mohan C. Vemuri Life Technologies, USA Session Bp I BIOPHARMACEUTICALS, BIOGENERICS & BIOSIMILARS Chairman: Prof. Hescheler Institut für Neurophysiologie der Universität zu Köln Köln Session Ag1 AGRICULTURAL BIOTECHNOLOGY: SCOPE & CHALLENGES Chairman: Dr. Ganesh M. Kishore CEO of Malaysian Government Investment Branch Session An I GLOBAL CHALLENGES AND THE FUTURE OF ANIMAL BIOTECHNOLOGY IN THE 21ST CENTURY Chairman: Dr. Lalji Singh Scientist Emeritus CCMB, Hyderabad 1.Prof. Agapios Sachinidis, University of Koln, Germany (Embryonic stem cell model for drug discovery: Alternative to Animal testing) 2.Dr. N. K. Mehra, AIIMS, New Delhi (Bone Marrow Donor Program – Awareness & Functional Aspect) 3.Dr. Deepa Bharatiya, Stem Cell Biology, National Institute for Research in Reproductive Health, Mumbai Sponsor’s Presentation Dr. Tomas Landh, Director of strategy and sourcing, Novo Nordisk A/S, Denmark 1. Dr. Anand Mushesh Gautam, Sourcing Director, Novo Nordisk A/S, Denmark ( Novo Nordisk’s focus on biological to treat chronic inflammatory auto immune diseases) 2. Dr. Anand Kumar, Associate Vice President, Wockhardt, India 1. Dr. Ganesh M. Kishore CEO of Malaysian Government Investment Branch (Overview of Ag Biotechnology) 2.Dr. G. Selvaraj, PBI-Saskatoon, Canada (Crop genomics& its potential in breeding ¤t status) 3.Dr. Anand Kumar New Delhi, IARI, New Delhi (GM Crops and Food Security in India) Brief Note Prof. C. Channa Reddy Penn State University, USA 1.Prof. Wansheng Liu, Penn State University, USA (Decoding the Bovine Y chromosome) 2. Dr. Matt Thomas Penn State University USA (Novel Strategies for the control of vector –borne diseases: ecological and (REALIZING CLINICAL POTENTIAL OF EMBRYONIC STEM CELL) 4.Dr. H. S. Chhabra, Chief of Spine Service & Medical Director, Indian Spinal Injury Centre, New Delhi (Cellular Therapies (Including Stem Cell treatment) for Human SCI – Fact or Fiction) (Physiochemcial comparability of biosimilars) 3. Dr. Fernando de Mora, SALUPHARMA BIOSIMILARS SA Chairman / Department of Pharmacology, Therapeutics and Toxicology (Edificio V) Universitat Autònoma de Barcelona Spain 4. Dr. John Hyde Jm Hyde consulting, Inc., USA. (Innovations in process design and Engineering for Biopharmaceuticals) evolutionally perspectives) 3. Dr. Satish Kumar, Scientist CCMB, Hyderabad (Molecular Characterization and Utilization of Livestock Genetic Resources of India) 13.00–15.00 Lunch and visit to the industry exhibition area 15.00–16.30 Session Mb II STEM CELL THERAPY II Chairman: Dr. D. Balasubramanian Director (research) L. V. Prasad Eye Institute Hyderabad INDIA Session Bp II DRUG DISCOVERY AND DEVELOPMENT : POTENTIALS AND CHALLENGES-I Dr. Ramamurthi Narayanan, Advanced Technology Centre, Tata Consulting Services, Hyderabad, India Session Ag II BIOTECH CROPS: DEVELOPMENT & COMMERCIALIZATION CHALLENGES Chairman: Dr. Kiran Sharma ICRISAT Hyderabad Session An II ENHANCING ANIMAL PRODUCTIVITY THROUGH PROVEN BIOTECHNOLOGIES Chairman: Prof. Chris Hodgson Moredun Research Institute, UK   Brief Note: 5. Dr. Joeri Borstlap, Coordinator, Regenerative Medicine Initiative Germany – RMIG, Berlin (Germany and India, Partners in Regenerative Medicine) 6. Dr. Gustav Steinhoff Director Department of Cardiac Surgery University of Rostock and German Reference and Translation Center for Cardiac Stem Cell Therapy “Cardiac Stem Cell Therapy- Clinical experience since 2001” 7. Mr. Satyen Sanhavi, Chief Scientific Officer, Regenerative Medical Services Pvt. Ltd, UK (Stem cell Application in Orthopedics) 8. Dr. Gopal Pande Scientist CCMB Hyderabad 5. Dr. C.S. N. Murthy, CEO Aurigene Discovery Technologies Ltd (Emergence of Drug Discovery collaboration opportunities in India: A case study from Aurigene’s experience) 6. Dr. Nagendra lingaraj (Large-conductance potassium channels as portal of drug delivery to diseased brain) 7. Dr. Raman Venkataraman , University of Pittsburgh, USA (Pharmacokinetics-Pharmacodynamics in optimizing drug development) 4. Dr. Balasubramaniam Tamilnadu Agricultural University (Public sector perspectives) 5. Dr. Rashmi Nair*, Monsanto, Mumbai (Private sector Perspectives) 6.Dr. Kiran Sharma ICRISAT Hyderabad (Public –Private sector Perspectives) 4. Dr. Chris Hodgson, Moredun Towards the development of novel vaccines against diseases of bovids caused by Pasteurella multocida) 5. Prof. Ramesh Ramachendran, Penn State University, USA (Novel Adipose Tissue Hormones in Metabolic Diseases and Animal Biotechnology) Research Institute, UK 16.30 – 17.00 Tea / coffee Break 17:00-18:30 Session Mb III NANOMEDICINE Chairman: Dr. Sitaramaiah Mokkapati Deputy Director General ICMR , New Delhi Session Bp III DRUG DISCOVERY AND DEVELOPMENT : POTENTIALS AND CHALLENGES-II Dr Venkat Jasti , Managing Director, Suven Pharmaceuticals, Hyderabad, India. Session Ag III CURRENT TRENDS AND ISSUES IN SEED INDUSTRY Chairman: Mr. Vijayraghavan, Sathguru Management Consultants, Hyderabad Session An III APPLICATION OF BIOTECHNOLOGY TO IMPROVING ANIMAL AND HUMAN HEALTH – PART I Chairman: Prof. Vivek Kapur Penn state University, USA 9. Dr. Mohan Rao, Director, Centre for Cell and Molecular Biology (CCMB), Hyderabad (Biomedical Applications of Nanotechnology: An Overview) 10. Dr. Yousef haik, Chief – CREN and Dubai university (Nanotechnology based approach to cancer management) 11. Dr. Amit Misra, CDRI, Lucknow (Converging Technologies for Tissue Regeneration and Body-friendly Implants) 8. Dr. Pingfan Rao, Institute of Biotechnology, Fuzhou University, China (Hemopoietic Peptides as Drug Candidates for Anemia) 9. Dr. Nandini Kishore Pfizer, St. Louis Laboratories USA (Drug discovery for inflammatory Diseases in the Genomics Era: opportunities and challenges) 10. Prof. P. Reddanna, University of Hyderabad, India (Leave early discovery to academics & Focus on Late discovery by Industry) 11. Prof. Prabhat Arya Chemical Biology Program, Institute of Life Sciences Hyderabad, India (Chemical Biology to Drug Discovery Challenges and Opportunities in the Post-Genomic Arena) 7. Chairman: Mr. Vijayraghavan, Sathguru Management Consultants, Hyderabad (Technology Partnerships) 8. Dr. Aravind Kapur RAASI Seeds, Tamilnadu (Availability of Technologies) 9. Dr. S.R. Rao, Advisor-DBT, New Delhi (Technology Transfer) 6. Prof. Bhushan Jayarao, Penn State University, USA (Antimicrobial Resistant Bacteria and Food Safety: An Emerging Global Issue) 7. Dr. Vivek J. Kapur, Penn state University, USA (Microbial Pathogenomics – A translational approach to developing the next generation of animal and human vaccines & diagnostics) 8. Prof. Troy Ott, Professor of Reproductive Biology, Penn State University, USA (Early Detection of Viral Infections Improves Biosecurity in Animal Agriculture) 18.30 Onwards Visit to Industry exhibition area 19:30-21:00 CEO Conclave “Reevaluating Business Models – What are the world’s best entrepreneurs doing?” -Coordinated by Ernst & Young, Hyderabad Followed by Cocktail Dinner Day 3 – February 5, 2010 08:00 Onwards Registrations Continues 09:00-10:00  Panel Discussion (Common for all tracks) - “International Venture Funds perspective of funding life science startups in India” – Coordinated by Alexandria Equities Management (India) Private Limited 1.Dr.Sunny Sharma Senior Managing Director OrbiMed Advisors, Mumbai 2. Mr. Varma S. Rudraraju Chairman & CEO Aizant Drug Research Solutions Private Limited, Hyderabad 3. Mr. N.G. Badari Narayan Managing Director Relisys Medical Devices Hyderabad 4. Mr. Ananth Rao Angel Investor 5. Dr Jasmin Patel Managing Director Fidelity, Haryana 6. Mr. Srinivas Ventrapragada CEO, Clintox Bioservices Hyderabad 7. Dr. Prasada Reddy Research Policy Institute School of Economics and Management Lund University, Sweden. Medical Biotechnology (Mb) Coordinators: Dr. Gurunath Reddy Dr. CM Habibullah, CLRD Dr. Vijayakumar, NIMS Biopharmaceuticals (Bp) Coordinators: Prof. P. Reddanna, Univ. of Hyd. Agri Biotechnology (Ag) Coordinator: Dr. Kiran Sharma, ICRISAT Animal Biotechnology (An) Coordinators: Dr. Channa Reddy, Penn. State Univ. Dr. Satish Kumar, CCMB 10:00-11:30 Session Mb IV PRE-CLINICAL AND CLINICAL TRIALS Chairman: Prof. Senthil J. Rajappa Department of Medical Oncology NIMS, Hyderabad, INDIA 12. Dr. Vivek Ahuja, Regional Director, Asia Pacific, Baxter Healthcare ( Structuring clinical trails enterprise in India) 13. Dr. M.U.R.Naidu, NIMS, India (Ethical issues in clinical research in developing countries) 14. Dr. Olivier BLIN CIC-UPCET-Fédération of Pharmacology Marseille UNIVERSITE de la MEDITERRANEE : INCM FRANCE Session Bp IV EMERGING BIOTECH PRODUCTS IN HEALTH CARE INDUSTRY Dr. Gowrishankar J Director, Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India. 12. Dr. Uptal Bhadra, Scientist, Centre for Cell and Molecular Biology (CCMB), Hyderabad ( RNA based technologies) 13. Dr. Madhavan Nair, Florida International University, USA ( Multifunctional Magnetic Nanocarrier for Drug Targeting to Brain) 14. Dr. Pawan K Dhar Senior Scientist & Lab Head, Synthetic Biology at RIKEN, Japan. (The emerging field of Synthetic Biology: potentials and prospects) Session Ag IV OPPORTUNITIES AND CHALLENGES FACING THE INDIAN FOOD SECTOR (Panel Discussion) Chairman: Dr. Swapan Datta, ICAR, New Delhi 10. Dr. Swapan Datta DDG-Crops, ICAR, New Delhi 11.Dr. K.K. Narayanan, Managing Director, Metahelix, Bangalore Session An IV APPLICATION OF BIOTECHNOLOGY TO IMPROVING ANIMAL AND HUMAN HEALTH – PART II Chairman: Prof. Peter Hudson Penn State University, USA 9. Dr. Peter Hudson, Willoman Professor of Biology, Penn State University, USA(Growing issues in the emergence of zoonotic diseases) 10.Prof. Isabella Cattadori, Penn State University, USA (Parasite Co-infections, Immunity & Host Heterogeneity- Key Issues for understanding Disease Transmission) 11. Dr. Nita Bharti Penn State University USA 11:30-12:00 Tea / Coffee Break 12:00–13:30 Session Mb V MOLECULAR DIAGNOSTICS 15. Dr. Chandak, Scientist, CCMB, Hyderabad (DNA-based Molecular Diagnostics Technologies: Past, present and future) 16. Dr. Manmohan Parida, Deputy Director, DRDE, Gwalior (Gene Amplification tools In Clinical Diagnosis: A two decades journey from PCR to LAMP ) 17. Prof. P.V.L. Rao, DRDE, Gwalior (On-line detection technologies: Microchips, and Biosensors) Session Bp V VACCINE BUSINESS : GLOBAL PERSPECTIVE Chairman: Dr. Varaprasad Reddy, Managing Director, Shantha Biotechnics, Hyderabad 15. Dr. Alexander Von Gobain CEO, Intercell AG, Austria (Intercell - a case study: utilizing global alliances to develop and to launch vaccines for developed and less devolved countries) 16. Dr. Niranjan Kumar, Chairman& CEO ABS Inc USA & ABSNOVACELLS Ltd. (Pandemic influenza Vaccine Prepare-dness: Comparison between developed and developing countries; Paradigm shift of Bird flu vs. Swine Flu Biomanufacturing and regulatory Concerns) 17.Dr. Mahesh Bhalgat, Biological E. Limited, Hyderabad (Second generation cervical cancer vaccine development) Session Ag V IPR AND BIOSAFETY REGULATIONS ON BIOTECH CROPS IN INDIA Chairman: Dr. S. Nagarajan Plant Variety protection Authority, New Delhi 12. Dr. S.R. Rao, Advisor-DBT, New Delhi (Biosafety Regulations) 13.Dr. Malathi Lakshmikumaran Attorney, New Delhi (Intellectual Property Rights) 14.Dr. S. Nagarajan, Plant Variety protection Authority, New Delhi (Biosafety and Registration of Transgenic Crops under the PPV&FR Act) Session An V BIOMEDICAL APPLICATIONS OF ANIMAL BIOTECHNOLOGY Chairman: Prof. Hafeez, Vice Chancellor, Veterinary University, Tirupati 12. Prof. Avery August, Penn State University, USA (Animal models of human respiratory disease) 13. Dr. Raffaella Corvi , European commission Joint Research Centre Institute for Health and Consumer Protection 14. Dr. Matthew Joseph Ferrari, Penn State University, USA (Using computational models to inform vaccine policy in West Africa) 15. Prof. Biao He, Penn State University, USA (A novel platform for developing vaccine against H5N1) 13.30–15.30 Lunch and visit to the industry exhibition area 15:30-17:00 Session Mb VI BIOMEDICAL ENGINEERING Chairman: Dr. Prasada Reddy Research Policy Institute School of Economics and Management, Lund University Sweden 18. Dr. Janakiraman Ramachandran, Chairman, Gangagen Inc, Bangalore (Novel Therapies for Antibiotic-Resistant Infection through Phage Engineering) 19.Dr. Boris Rubinsky, Professor of Graduate School, University of California at Berkeley, USA (Technological Breakthrough in Societal BioEngineering for Economically disadvantaged People and Societies") 20. Dr. Narayan R. Raju, Director, Pathology Research Laboratory Inc, San Francisco, USA (Medical Device Development and Clinical Trials. "The Good, Bad and Ugly”) 21. Dr. Sameul JK Abraham, Director of NCRM, Chennai (Biomimetics - Where are we?) Session Bp VI ANTI-CANCER DRUGS: ISSUES AND CHALLENGES Chairman: Dr. A. K. S. Bhujanga Rao, NATCO Pharma, Hyderabad Session Ag VI TECHNOLOGY PARTNERSHIPS (Panel Discussion) Chairman: Dr. P.V. Sagar VIBHA Seeds Session An VI THE BUSINESS OF ANIMAL BIOTECHNOLOGY Chairman: Dr. George John, Sr. Advisor, Department of Biotechnology, New Delhi 18. Dr. Raghavendra Dubey, Switzerland (Developing 2-Methoxyestradiol as a Therapeutic Agent for Multiple Proliferative Disorders: The risks, Benefits and Future) 19. Dr. Sagarika Kanjilal, Hershey Medical Center, USA (Fibrosarcoma; Molecular profiling of disease progression) 20.Dr. Yoshikazu Kurosawa, Japan (Novel targets – Tumor associated antigens) Session Ag VI TECHNOLOGY PARTNERSHIPS (Panel Discussion) Chairman: Dr. P.V. Sagar VIBHA Seeds 15. Dr. P. V. Sagar Chairman & CEO, VIBHA Seeds 16. Dr. VR Kaundinya CEO, ADVANTA 17. Mr. Prabhakar Rao CEO, Nuziveedu Seeds Session An VI THE BUSINESS OF ANIMAL BIOTECHNOLOGY Chairman: Dr. George John, Sr. Advisor, Department of Biotechnology, New Delhi 16. Dr. Joseph Shaw, Chairman and CEO Syntiron, LLC USA (How to nurture and operate a successful Biotechnology company) 17. Dr. Richard Mole, Chief Operating Officer, Inocul8 Edinburgh, UK (Factors affecting the development of new livestock vaccines) 18. Dr. Nanda Kumar* REED SMITH LLP USA 17.00 Onwards Tea / Coffee Break and Visit to Industry exhibition area 18.00 - 21.00 Indo - European Networking Reception 19:30 - 21:00 FABA Business Session (Only for Management Committee Members and Invitees) Day 4 – February 6, 2010 08:00 Onwards Registrations Continues… 09:00-10:00 Panel Discussion (Common for all tracks) “Strategies to make India a Contract Research Organizations (CRO) hub in Asia” - Coordinated by Mr. Vishal Goel, Managing Director / Head of India, Alexandria Equities Management (India) Private Limited 1. Dr. S. P. Vasireddi Chairman & Managing Director Vimta Labs Limited Hyderabad 2. Dr. Kailash Swarna, Senior Vice President & Chief Operating Officer Jubilant Global Drug Discovery & Development 3. Dr. Rajeev Soni President & COO PREMAS Biotech Pvt. Ltd., Haryana 4. Mr. Carl Weissman President and CEO, Accelerator, USA 10:00-10:30 Tea / Coffee Break 10:30–12:00 Plenary Lectures (Common for all tracks) Lecture I- Mr. Carl Weissman, President and CEO, Accelerator, USA (“Accelerator - Unique model for incubation”) Lecture II - Dr. Tipvon Parinyasiri, Director, Food Control Division, Food and Drug Administration, Ministry of Public Health, Bangkok, Thailand (Food Processing and Safety: Thailand and India, Potential Synergy) Lecture III - Prof. Raif Vasilov, President, Russian Biotechnology Society, Russia Lecture IV-Dr. Swaroop Vakkalanka, Managing Director & CEO, Incozen Therapeutics Pvt Ltd, HYDERABAD (“How to start Discovery based R&D company in India”) 12:00–13:30 Valedictory Ceremony Chief Guest : Shri. Ghulam Nabi Azad, Hon’ble Minister for Health and family welfare, Govt. of India* Keynote speaker : Dr. V.M. Katoch, Director General, Indian Council of Medical Research, Govt. of India Special Address : Dr. William Dar, Director General, ICRISAT Prof. Seyed E. Hasnain, Vice Chancellor, University of Hyderabad; Chairman, BioAsia Advisory Board Guests of Honour: Dr. Manel Balcells, Hon’ble President, Biocat, Spain Dr. Abbas S Lofti, Hon’ble Dy. Minister, Ministry of Education, Govt. of Iran and Chairperson, Iran Chapter of FABA Mr. B. P. Acharya, I.A.S., Chairman & Managing Director, APIIC Ltd and Chairman, BioAsia 2010 Organising Committee Dr. B. S. Bajaj, Secretary General, FABA; and Convener, BioAsia 2010 “Two whitepapers on PPP in Biotech and Funding options for drug discovery” would be released by the Knowledge Partner - Grant Thornton Award Ceremony: 1) FABA Special Awards 2) Dr. Y. S. R. Innovation Award 3) BioAsia Young minds Award 4) Best Exhibitor Awards 13:30 “Interactive Healthcare Leadership Luncheon Meet”, Sponsored by Alexandria Equities Management (India) Private Limited. BioAsia 2010 Concludes